BBS-Bioactive Bone Substitutes Oyj Balance Sheet Health
Financial Health criteria checks 2/6
BBS-Bioactive Bone Substitutes Oyj has a total shareholder equity of €5.1M and total debt of €4.8M, which brings its debt-to-equity ratio to 93%. Its total assets and total liabilities are €10.6M and €5.5M respectively.
Key information
93.0%
Debt to equity ratio
€4.75m
Debt
Interest coverage ratio | n/a |
Cash | €1.97m |
Equity | €5.11m |
Total liabilities | €5.50m |
Total assets | €10.61m |
Recent financial health updates
We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt
Sep 16BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Dec 20BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Sep 02Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?
Feb 27Recent updates
We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt
Sep 16BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Dec 20BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Sep 02Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?
Feb 27Financial Position Analysis
Short Term Liabilities: BONEH's short term assets (€2.0M) exceed its short term liabilities (€1.4M).
Long Term Liabilities: BONEH's short term assets (€2.0M) do not cover its long term liabilities (€4.1M).
Debt to Equity History and Analysis
Debt Level: BONEH's net debt to equity ratio (54.5%) is considered high.
Reducing Debt: BONEH's debt to equity ratio has reduced from 143.3% to 93% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BONEH has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BONEH has less than a year of cash runway if free cash flow continues to reduce at historical rates of 14.8% each year